Resident of Rheumatology at Centro Hospitalar de Lisboa Ocidental, EPE
Dr. José Marona initiated Rheumatology residentship in 2016 at Hospital Egas Moniz – CHLO (Lisbon, Portugal). Since 2017 he is also a volunteer lecturer of Rheumatology in NOVA Medical School (Lisbon, Portugal) and a collaborator at the Center of Chronic Diseases from NOVA Medical School (CEDOC-NMS). He has participated in several clinical trials and research projects with particular focus on the impact of Biosimilars in the Portuguese market.
Title: Switching to biosimilars: What have we learned?
Experience of Portuguese rheumatology centers in switching from biooriginators to biosimilars
- General principles of risk management
- Risk management plan (RMP): GVP guidelines
- EU and US approach: RMP vis-à-vis REMS